Likes
Time to time salary ho jati hai.
i
Rusan Pharma
Company name | Avg Annual Salary | Open Jobs |
---|---|---|
Sun Pharmaceutical Industries Operator Salary
1 - 9 years exp. (144 salaries) | ₹1.1 L/yr - ₹5.4 L/yr
25%
more | |
Cipla Operator Salary
0 - 7 years exp. (155 salaries) | ₹1 L/yr - ₹5.4 L/yr
17%
more | 1 job opening |
Login to view exact salary
| ||
Biocon Limited Operator Salary
0 - 9 years exp. (10 salaries) | ₹1.5 L/yr - ₹5.5 L/yr
36%
more | |
Zydus Lifesciences Operator Salary
1 - 8 years exp. (264 salaries) | ₹1.4 L/yr - ₹5.6 L/yr
12%
more | 1 job opening |
Glenmark Pharmaceuticals Operator Salary
1 - 7 years exp. (84 salaries) | ₹1 L/yr - ₹4.6 L/yr
15%
more | |
Aurobindo Pharma Operator Salary
0 - 8 years exp. (91 salaries) | ₹1.6 L/yr - ₹6.7 L/yr
30%
more | |
Lupin Operator Salary
0 - 5 years exp. (135 salaries) | ₹1 L/yr - ₹5 L/yr
2%
more | |
Torrent Pharmaceuticals Operator Salary
0 - 5 years exp. (14 salaries) | ₹1.7 L/yr - ₹3 L/yr
8%
less | |
DIVI'S Laboratories Operator Salary
1 - 6 years exp. (4 salaries) | ₹2.4 L/yr - ₹2.5 L/yr
3%
less | |
Kusum Healthcare Operator Salary
2 - 10 years exp. (10 salaries) | ₹2 L/yr - ₹6.5 L/yr
52%
more | |
Apothecon Pharmaceuticals Operator Salary
3 - 7 years exp. (10 salaries) | ₹2 L/yr - ₹4 L/yr
22%
more | |
Login to view exact salary
| ||
Gracure Pharmaceuticals Operator Salary
1 - 7 years exp. (10 salaries) | ₹1.9 L/yr - ₹4.3 L/yr
28%
more | |
Otsuka Pharmaceutical India Private Limited Operator Salary
0 - 5 years exp. (7 salaries) | ₹2 L/yr - ₹2.9 L/yr
1%
less | |
Inventia Healthcare Operator Salary
4 - 6 years exp. (4 salaries) | ₹2.8 L/yr - ₹4.9 L/yr
45%
more | |
Last Updated: 18 Aug 2024
Experience | Avg Annual Salary |
---|---|
1 year (3 salaries) |
₹1.4
L/yr
- ₹4
L/yr
|
2 years (6 salaries) |
₹1.5
L/yr
- ₹3
L/yr
|
Login to view exact salary
| |
3 years (3 salaries) |
₹2
L/yr
- ₹2.5
L/yr
|
4 years (AmbitionBox Estimate) |
₹2
L/yr
- ₹3
L/yr
|
5 years (AmbitionBox Estimate) |
₹2.5
L/yr
- ₹3
L/yr
|
Discover interview dos and don'ts from real experiences
Top trending discussions